Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trial-Reference-Cited by-同舟云学术

Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trial

Published:2023-06 Issue:3 Volume:8 Page:101576
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Girard N.,Ponce Aix S.,Cedres S.,Berghmans T.,Burgers S.,Toffart A.-C.,Popat S.,Janssens A.,Gervais R.,Hochstenbag M.,Silva M.,Burger I.A.,Prosch H.,Stahel R.,Xenophontos E.,Pretzenbaher Y.,Neven A.,Peters S.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference36 articles.

1. Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Girard;Ann Oncol,2015

2. Thymic tumours and their special features;Basse;Eur Respir Rev,2021

3. Mesothelioma and thymic tumors: treatment challenges in (outside) a network setting;Imbimbo;Eur J Surg Oncol,2019

4. WHO histological classification of tumours of the thymus,2015

5. Systemic therapy in advanced thymic epithelial tumors: insights from the RYTHMIC prospective cohort;Merveilleux du Vignaux;J Thorac Oncol,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thymic epithelial tumor medical treatment: A narrative review;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Evolving treatment landscape in thymic epithelial tumors: From mechanism to therapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

3. Survival Outcome After Surgery in Patients With Thymoma Distant Recurrence;Journal of Thoracic Oncology;2024-07

4. Artemis: A Multicenter, Open-Label, Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of First-Line Carboplatin/Paclitaxel/Lenvatinib/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas;Clinical Lung Cancer;2024-06

5. Immunotherapy for Thymomas and Thymic Carcinomas: Current Status and Future Directions;Cancers;2024-03-30